Perseus Proteomics Inc. Logo

Perseus Proteomics Inc.

Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.

4882 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
目黒区駒場四丁目7番6号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Perseus Proteomics Inc. is a drug discovery biotechnology company founded in 2001 as a venture from the University of Tokyo. The company focuses on creating novel antibody-based therapeutics to treat cancer and other diseases, utilizing its proprietary and unique antibody technologies. Its business operations are structured around three core segments: Drug Discovery, which develops its pipeline of potential antibody drugs; Antibody Research Support Services for partner institutions; and the direct sale of antibody products and diagnostic reagents, such as ELISA kits. The company's mission is to contribute to global healthcare by developing innovative treatments for people suffering from diseases worldwide.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Perseus Proteomics Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 09:28
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-06-27 08:34
Registration Form
確認書
Japanese 8.2 KB
2025-06-27 08:33
Regulatory News Service
訂正有価証券報告書-第24期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2025-06-27 08:33
Registration Form
確認書
Japanese 8.2 KB
2025-06-27 08:32
Regulatory News Service
訂正有価証券報告書-第23期(2022/04/01-2023/03/31)
Japanese 1.5 MB
2025-06-27 08:32
Regulatory News Service
内部統制報告書-第25期(2024/04/01-2025/03/31)
Japanese 22.4 KB
2025-06-27 08:31
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-27 08:31
Annual Report
有価証券報告書-第25期(2024/04/01-2025/03/31)
Japanese 2.6 MB
2025-05-21 08:31
Regulatory News Service
臨時報告書
Japanese 20.2 KB
2024-11-14 07:34
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:34
Interim Report
半期報告書-第25期(2024/04/01-2025/03/31)
Japanese 163.4 KB
2024-06-20 07:40
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2024-06-20 07:34
Governance Information
内部統制報告書-第24期(2023/04/01-2024/03/31)
Japanese 21.2 KB
2024-06-20 07:34
Registration Form
確認書
Japanese 8.1 KB
2024-06-20 07:33
Annual Report
有価証券報告書-第24期(2023/04/01-2024/03/31)
Japanese 2.8 MB

Automate Your Workflow. Get a real-time feed of all Perseus Proteomics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Perseus Proteomics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea 102460
Roche Holding AG Logo
A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.
Switzerland RO
ROHTO PHARMACEUTICAL CO.,LTD. Logo
Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.
Japan 4527
RPbio Inc. Logo
A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.
South Korea 314140
Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.
Türkiye RTALB
SAMIL PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs for eye & liver diseases, with a broad portfolio & CDMO services.
South Korea 000520
SAMJIN PHARMACEUTICAL CO.,LTD Logo
Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.
South Korea 005500
SAMSUNG BIOLOGICS CO.,LTD. Logo
A CDMO providing end-to-end development and manufacturing services for the biopharma industry.
South Korea 207940
SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan 4592
SANIGEN Co., Ltd. Logo
Provides food safety solutions and genetic diagnostics for the entire food industry.
South Korea 188260

Talk to a Data Expert

Have a question? We'll get back to you promptly.